Cargando…
The taxanes: toxicity and quality of life considerations in advanced ovarian cancer
The taxanes paclitaxel and docetaxel show good activity in the management of advanced ovarian cancer when used in conjunction with platinum agents. Accumulating evidence from clinical studies, particularly the latest results from the phase III comparative SCOTROC study, indicates that the two drugs...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2003
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750618/ https://www.ncbi.nlm.nih.gov/pubmed/14661042 http://dx.doi.org/10.1038/sj.bjc.6601496 |